Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sanigen Co., Ltd. (188260:KRX), powered by AI.
Sanigen Co., Ltd. is currently trading at ₩1,707. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sanigen Co., Ltd. on Alpha Lenz.
Sanigen Co., Ltd.'s P/E ratio is -1.8.
“Sanigen Co., Ltd. trades at a P/E of -1.8 (undervalued) with modest ROE of -59.3%.”
Ask for details →Sanigen Co., Ltd. is a specialized biotechnology company known for its innovative solutions in the fields of molecular diagnostics and advanced genetic research. With a particular focus on the development of diagnostic kits and services, Sanigen aims to enhance the early detection and management of diseases through cutting-edge technologies. The company leverages its extensive expertise in next-generation sequencing and bioinformatics to offer comprehensive genomic profiling, which is crucial for personalized medicine and research. Sanigen's products and services serve various sectors, including healthcare, pharmaceuticals, and academic research, providing tools that aid in understanding genetic factors and disease mechanisms. As a key player in the biotechnology industry, Sanigen Co., Ltd. contributes significantly to advancements in medical diagnostics and personalized treatment strategies, positioning itself as a pivotal entity in the evolving landscape of healthcare and genetic research.
“Sanigen Co., Ltd. trades at a P/E of -1.8 (undervalued) with modest ROE of -59.3%.”
Ask for details →